GlassScriptPhysician profile
Bruce A Surosky
NPI 1215979018
$48,971.77
in general payments reported to CMS, 2019-2025
27 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,893 · 2020: $3,293 · 2021: $13K · 2022: $10K · 2023: $8,259 · 2024: $3,005 · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,040.10 |
| Food and Beverage | $1,232.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $30,321.82 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $15,565.93 | 2019-2021 | |
| Abbvie INC. | $884.12 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $513.04 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $270.42 | 2023-2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $206.07 | 2019-2022 | |
| Exact Sciences Corporation | $185.82 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $153.37 | 2019-2022 | |
| Lupin INC. | $116.51 | 2019-2020 | |
| Agile Therapeutics, INC. | $104.62 | 2022-2023 | Twirla |
| Boston Scientific Corporation | $75.85 | 2019-2021 | |
| Amgen INC. | $74.02 | 2024-2025 | Evenity, Prolia |
| Urovant Sciences INC | $72.29 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.24 | 2025 | Caplyta |
| Coopersurgical, INC. | $52.19 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $40.12 | 2022-2023 | Veozah |
| Medicem INC. | $38.21 | 2023 | |
| Medtronic, INC. | $33.51 | 2021-2022 | |
| Sage Therapeutics, LLC | $31.08 | 2020 | |
| Allergan, INC. | $25.73 | 2019-2020 | |
| Ge Healthcare | $22.31 | 2021 | |
| Dexcom, INC. | $21.79 | 2024 | Dexcom G6 Transmitter |
| Scynexis, INC. | $21.32 | 2022 | |
| Alkermes, INC. | $20.76 | 2025 | Vivitrol |
| Biogen, INC. | $20.13 | 2024 | |
| Hologic Sales and Service, LLC | $18.56 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Surosky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.